A retrospective study analysing correlation between irAEs and clinical outcome in metastatic renal cell carcinoma patients treated with Nivolumab
Latest Information Update: 27 Oct 2021
At a glance
- Drugs Nivolumab (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions; Therapeutic Use
- 27 Oct 2021 New trial record
- 13 Sep 2021 Results presented at the 116th Annual Meeting of the American Urological Association